Evaluation of the Biodistribution of Serinolamide-Derivatized C(60) Fullerene

Carbon nanoparticles have consistently been of great interest in medicine. However, there are currently no clinical materials based on carbon nanoparticles, due to inconsistent biodistribution and excretion data. In this work, we have synthesized a novel C(60) derivative with a metal chelating agent...

Descripción completa

Detalles Bibliográficos
Autores principales: Zaibaq, Nicholas G., Pollard, Alyssa C., Collins, Michael J., Pisaneschi, Federica, Pagel, Mark D., Wilson, Lon J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7023239/
https://www.ncbi.nlm.nih.gov/pubmed/31941058
http://dx.doi.org/10.3390/nano10010143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7023239/
https://www.ncbi.nlm.nih.gov/pubmed/31941058
http://dx.doi.org/10.3390/nano10010143

Ejemplares similares